Oruka Therapeutics ORKA
NASDAQ ORKA
$82.15 -2.04 (-2.42%)
At close: Sep 29, 2026 · 4:00 PM EDT

Oruka Therapeutics (ORKA) Share-based Compensation (2010 - 2026)

Updated

Oruka Therapeutics' Share-based Compensation came in at $7.28 million for Q2 2026, up 43.5% from $5.08 million a year earlier and up 4.5% from the prior quarter.

Analysis

Oruka Therapeutics (ORKA) Share-based Compensation (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Oruka Therapeutics reported Share-based Compensation of $28.53 million, up 18.3% year-over-year; for FY2025, it came in at $24.24 million, up 62.5% from FY2024.

  • Share-based Compensation carries a five-year compound annual growth rate of 255.0% (FY2020 to FY2025).
  • Going back by year, Share-based Compensation was $14.92 million in FY2024, $686,000 in FY2023 (+23.4%), $556,000 in FY2022 (+11.9%) and $497,000 in FY2021.
  • The five-year range for quarterly Share-based Compensation is $85,000 (Q1 2024) to $10.17 million (Q3 2025).
  • Year-over-year, Share-based Compensation increased in four of the last five quarters, with growth averaging 144.5%.
  • The fastest year-over-year change in Share-based Compensation over five years came in Q2 2025 (growth of 643.3%), and the weakest in Q1 2024 (a decline of 58.3%).
  • Business Quant data shows ORKA's Share-based Compensation at $6.97 million (Q1 2026), $4.12 million (Q4 2025) and $10.17 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 458.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 166.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 231.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 170.20 Mn
10 Oruka Therapeutics 5.29 Bn 3.34 Bn - 7.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.28 Mn
Mar 31, 2026 6.97 Mn
Dec 31, 2025 4.12 Mn
Sep 30, 2025 10.17 Mn
Jun 30, 2025 5.08 Mn
Mar 31, 2025 4.88 Mn
Dec 31, 2024 5.15 Mn
Sep 30, 2024 9.00 Mn
Jun 30, 2024 683,000.00
Mar 31, 2024 85,000.00
Dec 31, 2023 141,000.00
Sep 30, 2023 154,000.00
Jun 30, 2023 187,000.00
Mar 31, 2023 204,000.00
Dec 31, 2022 120,000.00
Sep 30, 2022 97,000.00
Jun 30, 2022 172,000.00
Mar 31, 2022 167,000.00
Dec 31, 2021 119,000.00
Sep 30, 2021 104,000.00
API Access

Oruka Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ORKA&period=max&api_key=YOUR_API_KEY